TABLE 5-1 Dietary Potassium and Serum Potassium Concentrations
|
Reference |
Subjects |
Dietary Potassium (K),a g/d (mmol/d) |
Serum Potassium (mmol/L) ± standard deviation |
|
Dluhy et al., 1972 |
8 women, 2 men, crossover 5 subjects, 6–7 d, 0.23 g (10 mmol) sodium (Na)/d 5 subjects, 3 d, 4.6 g (200 mmol) Na/d |
1.6 (40) 7.8 (200) 1.6 (40) 7.8 (200) |
4.1 ± 0.1b 4.3 ± 0.1b 4.0 ± 0.1b 4.2 ± 0.1b |
|
Zoccali et al., 1985 |
5-d crossover, 10 men |
3.0 (76) 6.9 (176) |
3.9 ± 0.1b 4.3 ± 0.1b |
|
Hene et al., 1986 |
18-d parallel, 6 men |
3.1 (80) 11.7 (300) |
4.26 ± 0.28b 4.39 ± 0.32b |
|
Witzgall and Behr, 1986 |
6 d on high K diet, 16 men |
2.3 g (60) 10.1 g (260) |
4.2 ± 0.3b 4.6 ± 0.3c |
|
Grimm et al., 1990 |
2.2 yr supplement/placebo intervention, 287 men, 45–68 yr, baseline urinary K = 2.2 g/d |
+ 3.8 (96) + 0 |
4.2b 4.5c The difference averaged 0.26 mmol/L over the 2-yr period |
|
Rabelink et al., 1990 |
20 d, 6 men |
3.9 (100) 15.6 (400) |
3.75 ± 0.16b 4.22 ± 0.12b |
|
Clinkingbeard et al., 1991 |
3-d crossover, 8 men |
0.39 (10) 7.8 (200) |
3.8 ± 0.1b 4.3 ± 0.2c |
|
Deriaz et al., 1991 |
5-d crossover, 8 men |
2.7 (69) 6.4 (163) |
4.1 ± 0.2b 3.8 ± 0.1c |
|
Valdes et al., 1991 |
4-wk crossover, 24 men and women, provided placebo or supplement |
+ 0 + 2.5 (64) |
3.8 ± 0.1b 4.1 ± 0.1c |
|
Smith et al., 1992 |
4-d crossover, 22 men and women |
2.7 (70) 4.7 (120) |
3.9 ± 0.1b 4.3 ± 0.1c |
|
Sebastian et al., 1994 |
18 d, 18 postmenopausal women |
2.3 (60) + 4.7 (120) |
3.9 ± 0.15b 4.0 ± 0.2b |
|
Morris et al., 1999b |
38 men, parallel |
+ 1.17 (30) 4.7 (120) |
3.7 ± 0.2b 4.0 ± 0.2c |
|
Coruzzi et al., 2001 |
10-d isocaloric crossover, 8 men, 3 women |
0.70 (18) 3.1 (80) |
3.2 ± 0.1 (standard error)b 4.1 ± 0.05c |
|
a “+” means amount of potassium provided as a supplement. b,c Values with different superscripts differed significantly at p < 0.05 or less. |
|||